Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.
|Medical device firm Belluscura has revealed plans for a London float
Manufacture of consumer electronics
|Date||Amount||No. of Investors|
|Increase in Cash||£1.8m||£-833.63k|
Financial data drawn from last filed accounts don't necessarily reflect current trading activity.
Statement of capital following an allotment of shares on 2019-05-03
Confirmation statement made on 2018-12-09 with updates
Registered office address changed from 82 st. John Street Farringdon London EC1M 4JN England to 15 Fetter Lane London EC4A 1BW on 2018-12-19
|DYER, Anthony Stephen||Secretary||17/11/2017||British|
|DYER, Anthony Stephen||Director||17/11/2017||British|